These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
370 related items for PubMed ID: 28301309
21. Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging. Hoeks CM, Hambrock T, Yakar D, Hulsbergen-van de Kaa CA, Feuth T, Witjes JA, Fütterer JJ, Barentsz JO. Radiology; 2013 Jan; 266(1):207-17. PubMed ID: 23143029 [Abstract] [Full Text] [Related]
22. Middle ear cholesteatoma: non-echo-planar diffusion-weighted MR imaging versus delayed gadolinium-enhanced T1-weighted MR imaging--value in detection. De Foer B, Vercruysse JP, Bernaerts A, Meersschaert J, Kenis C, Pouillon M, De Beuckeleer L, Michiels J, Bogaerts K, Deckers F, Somers T, Hermans R, Offeciers E, Casselman JW. Radiology; 2010 Jun; 255(3):866-72. PubMed ID: 20501723 [Abstract] [Full Text] [Related]
23. Preoperative detection of small pancreatic carcinoma: value of adding diffusion-weighted imaging to conventional MR imaging for improving confidence level. Park MJ, Kim YK, Choi SY, Rhim H, Lee WJ, Choi D. Radiology; 2014 Nov; 273(2):433-43. PubMed ID: 24991989 [Abstract] [Full Text] [Related]
24. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy. Park MJ, Kim SH, Lee SJ, Jang KM, Rhim H. Radiology; 2011 Sep; 260(3):771-80. PubMed ID: 21846762 [Abstract] [Full Text] [Related]
25. Survival outcomes of breast cancer patients who receive neoadjuvant chemotherapy: association with dynamic contrast-enhanced MR imaging with computer-aided evaluation. Yi A, Cho N, Im SA, Chang JM, Kim SJ, Moon HG, Han W, Park IA, Noh DY, Moon WK. Radiology; 2013 Sep; 268(3):662-72. PubMed ID: 23592770 [Abstract] [Full Text] [Related]
26. Combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging to predict neoadjuvant chemotherapy effect in FIGO stage IB2-IIA2 cervical cancers. Zhang A, Song J, Ma Z, Chen T. Radiol Med; 2020 Dec; 125(12):1233-1242. PubMed ID: 32424659 [Abstract] [Full Text] [Related]
27. Breast cancer: early prediction of response to neoadjuvant chemotherapy using parametric response maps for MR imaging. Cho N, Im SA, Park IA, Lee KH, Li M, Han W, Noh DY, Moon WK. Radiology; 2014 Aug; 272(2):385-96. PubMed ID: 24738612 [Abstract] [Full Text] [Related]
28. Bilateral diffusion-weighted MR imaging of breast tumors with submillimeter resolution using readout-segmented echo-planar imaging at 7 T. Bogner W, Pinker K, Zaric O, Baltzer P, Minarikova L, Porter D, Bago-Horvath Z, Dubsky P, Helbich TH, Trattnig S, Gruber S. Radiology; 2015 Jan; 274(1):74-84. PubMed ID: 25341078 [Abstract] [Full Text] [Related]
29. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Parikh T, Drew SJ, Lee VS, Wong S, Hecht EM, Babb JS, Taouli B. Radiology; 2008 Mar; 246(3):812-22. PubMed ID: 18223123 [Abstract] [Full Text] [Related]
30. High-Resolution Diffusion-Weighted Imaging Improves the Diagnostic Accuracy of Dynamic Contrast-Enhanced Sinonasal Magnetic Resonance Imaging. Wang F, Sha Y, Zhao M, Wan H, Zhang F, Cheng Y, Tang W. J Comput Assist Tomogr; 2017 Mar; 41(2):199-205. PubMed ID: 27560026 [Abstract] [Full Text] [Related]
34. Use of diffusion-weighted, intravoxel incoherent motion, and dynamic contrast-enhanced MR imaging in the assessment of response to radiotherapy of lytic bone metastases from breast cancer. Gaeta M, Benedetto C, Minutoli F, D'Angelo T, Amato E, Mazziotti S, Racchiusa S, Mormina E, Blandino A, Pergolizzi S. Acad Radiol; 2014 Oct; 21(10):1286-93. PubMed ID: 25088834 [Abstract] [Full Text] [Related]
35. Imaging Features of Gadoxetic Acid-enhanced and Diffusion-weighted MR Imaging for Identifying Cytokeratin 19-positive Hepatocellular Carcinoma: A Retrospective Observational Study. Choi SY, Kim SH, Park CK, Min JH, Lee JE, Choi YH, Lee BR. Radiology; 2018 Mar; 286(3):897-908. PubMed ID: 29166246 [Abstract] [Full Text] [Related]
36. Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging--comparison with contrast-enhanced MR imaging and pathologic findings. Woodhams R, Kakita S, Hata H, Iwabuchi K, Kuranami M, Gautam S, Hatabu H, Kan S, Mountford C. Radiology; 2010 Feb; 254(2):357-66. PubMed ID: 20093508 [Abstract] [Full Text] [Related]
37. Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy. Hahn SY, Ko EY, Han BK, Shin JH, Ko ES. Eur J Radiol; 2014 Feb; 83(2):283-8. PubMed ID: 24315957 [Abstract] [Full Text] [Related]